Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
Conditions
- Advanced Malignant Solid Neoplasm
- Metastatic Malignant Neoplasm in the Liver
- Metastatic Malignant Neoplasm in the Lung
- Metastatic Malignant Solid Neoplasm
Interventions
- OTHER: Hafnium Oxide-containing Nanoparticles NBTXR3
- RADIATION: Radiation Therapy
- RADIATION: Radiation Therapy
Sponsor
M.D. Anderson Cancer Center
Collaborators